Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies
ClinicalTrials.gov study NCT00670592. IPD Sharing: Not stated. Countries: 11. Publications: 0.
Clinical Study of SL19+22 CAR-T Cells for Relapsed or Refractory Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT05206071. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00002691. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Loncastuximab Tesirine and Venetoclax for Relapsed/ Refractory Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT05053659. IPD Sharing: NO. Countries: 1. Publications: 0.
Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia
ClinicalTrials.gov study NCT00005977. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Immunological Senescence Phenotype as a Resistance Profile to Pembrolizumab in Patients With Relapsed/Refractory Hodgkin's Lymphoma
ClinicalTrials.gov study NCT06733987. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody to Treat Non-hodgkin's Lymphoma
ClinicalTrials.gov study NCT01459887. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Brazilian Prospective Hodgkin Lymphoma Registry
ClinicalTrials.gov study NCT02589548. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prognosis of Patients With Relapsed/Refractory Hodgkin Lymphoma Treated With IGEV Induction Therapy Before HDCT With AHSCT
ClinicalTrials.gov study NCT01478191. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open Label, Phase 2 Study of CD19t-haNK and N-803 in Combination With Rituximab in Participants With Relapsed/ Refractory B-cell Non- Hodgkin Lymphoma.
ClinicalTrials.gov study NCT07125872. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Safety Analysis of Intravenous Rapid Infusion of Obinutuzumab in Patients With B-cell Non-Hodgkin's Lymphoma in China
ClinicalTrials.gov study NCT05510219. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Safety and Efficacy of PET-adapted Treatment With Nivolumab at the Fixed Dose 40 mg, Ifosfamide, Carboplatin, Etoposide (NICE-40) in Patients With Relapsed/Refractory Hodgkin Lymphoma
ClinicalTrials.gov study NCT04981899. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
An Early Clinical Study Evaluating the Safety and Efficacy of AcNK-Sup003 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT06693973. IPD Sharing: YES. Countries: 1. Publications: 0.
Rituximab & Combination Chemotherapy Followed by Transplantation in Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00007852. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice
ClinicalTrials.gov study NCT06008691. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bendamustine, Cytarabine, Etoposide and Melphalan (BeEAM) as Conditioning for Autologous Stem Cell Transplant (ASCT) in Aggressive Non Hodgkin's Lymphoma (NHL).
ClinicalTrials.gov study NCT01296256. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00026351. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Brentuximab Vedotin as Alternative to the Autologous Stem Cell Transplantation in Relapsed and Refractory Classical Hodgkin's Lymphoma (BASALT)
ClinicalTrials.gov study NCT03474133. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT00058461. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multicenter Study of Safety and Efficacy of PET-adapted Treatment With Nivolumab, Bendamustine, Gemcitabine, Vinorelbine (Nivo-BeGEV) in Patients With Relapsed/Refractory Hodgkin Lymphoma
ClinicalTrials.gov study NCT05660993. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.